CRIZOTINIB ACETATE

UNII:	FB99MH8KWZ
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₁H₂₂Cl₂FN₅O.C₂H₄O₂
Preferred Substance Name:	CRIZOTINIB ACETATE
InChIKey:	LFCVDLCLKZRGFW-UTONKHPSSA-N
GSRS Full Record:	FB99MH8KWZ i

877399-53-6
2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, acetate (1:1)
2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, monoacetate
Acetic acid, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
Crizotinib acetate
[3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine monoacetate

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CRIZOTINIB ACETATE

Synonyms and Mappings

Resources